193 related articles for article (PubMed ID: 26279147)
1. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study.
Kus T; Aktas G; Kalender ME; Sevinc A; Kul S; Suner A; Ulker E; Camci C
Support Care Cancer; 2016 Mar; 24(3):1175-9. PubMed ID: 26279147
[TBL] [Abstract][Full Text] [Related]
2. Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.
Ramanathan RK; Rothenberg ML; de Gramont A; Tournigand C; Goldberg RM; Gupta S; André T
Ann Oncol; 2010 Apr; 21(4):754-758. PubMed ID: 19887466
[TBL] [Abstract][Full Text] [Related]
3. The use of vitamin E in preventing taxane-induced peripheral neuropathy.
Heiba MA; Ismail SS; Sabry M; Bayoumy WAE; Kamal KA
Cancer Chemother Pharmacol; 2021 Dec; 88(6):931-939. PubMed ID: 34468794
[TBL] [Abstract][Full Text] [Related]
4. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
5. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
6. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
Hershman DL; Till C; Wright JD; Awad D; Ramsey SD; Barlow WE; Minasian LM; Unger J
J Clin Oncol; 2016 Sep; 34(25):3014-22. PubMed ID: 27325863
[TBL] [Abstract][Full Text] [Related]
8. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Hirsh V; Okamoto I; Hon JK; Page RD; Orsini J; Sakai H; Zhang H; Renschler MF; Socinski MA
J Thorac Oncol; 2014 Jan; 9(1):83-90. PubMed ID: 24346096
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
Myftiu B; Hundozi Z; Sermaxhaj F; Blyta A; Shala N; Jashari F; Qorraj Bytyqi H; Hyseni E; Kurtishi I
Med Sci Monit; 2022 Aug; 28():e937856. PubMed ID: 36042691
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
[TBL] [Abstract][Full Text] [Related]
12. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
Andersen Hammond E; Pitz M; Shay B
Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
[TBL] [Abstract][Full Text] [Related]
13. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case-control study.
Kus T; Aktas G; Alpak G; Kalender ME; Sevinc A; Kul S; Temizer M; Camci C
Support Care Cancer; 2016 May; 24(5):2085-2091. PubMed ID: 26546457
[TBL] [Abstract][Full Text] [Related]
15. GM1 for taxane-induced neuropathy in breast cancer.
Das M
Lancet Oncol; 2019 Jul; 20(7):e348. PubMed ID: 31130320
[No Abstract] [Full Text] [Related]
16. Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).
Mongiovi JM; Zirpoli GR; Cannioto R; Sucheston-Campbell LE; Hershman DL; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Thomas Budd G; Albain KS; Ambrosone CB; McCann SE
Breast Cancer Res; 2018 Nov; 20(1):146. PubMed ID: 30486865
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of lysophosphatidic acid receptor 1 are associated with the onset of taxane-induced peripheral neuropathy.
Tsuchida R; Tanabe Y; Nishizawa D; Ikeda K; Abe H; Inoue R; Kurano M; Yatomi Y; Tamura K; Takano T; Shimizu C; Uchida K; Sumitani M
Br J Anaesth; 2021 Aug; 127(2):e43-e46. PubMed ID: 34024637
[No Abstract] [Full Text] [Related]
18. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lafutidine, a histamine H2-receptor antagonist, for taxane-induced peripheral neuropathy in patients with gynecological malignancies.
Nagano H; Sanai H; Muraoka M; Takagi K
Gynecol Oncol; 2012 Oct; 127(1):172-4. PubMed ID: 22750259
[TBL] [Abstract][Full Text] [Related]
20. Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology.
Chen EI; Crew KD; Trivedi M; Awad D; Maurer M; Kalinsky K; Koller A; Patel P; Kim Kim J; Hershman DL
PLoS One; 2015; 10(12):e0145816. PubMed ID: 26710119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
